The Translational Research Office are pleased to announce that the Medical and Life Sciences Translational Fund (MLSTF) is NOW OPEN for applications.
MLSTF funds proof-of-concept projects to ‘pump-prime’ the translation of novel therapeutics, devices, diagnostics, and other therapeutic interventions toward clinical testing. The deadline for submissions through IRAMS is the 16th of September 2024.
This round will continue the Emerging Translational Innovators (ETI) route for early career researchers and feature the Innovation co-funding streams with Novo Nordisk, Oxford Biomedica, and Cancer Research Horizons. Submit your non-confidential expression of interest (EOI) by the 31st of July to be considered for one of the Innovation streams."
| Application Deadline Date |
16/09/2024 |
| Time |
23:59 |
| Application required? |
Apply Here |
